Seroconversion following measles immunisation
Swami, S.S.; Chandra, S.; Dudani, I.U.
Journal of Communicable Diseases 19(2): 141-145
1987
ISSN/ISBN: 0019-5138 PMID: 3454353 Document Number: 290661
Document emailed within 1 workday
Related Documents
Semba, R.D.; Munasir, Z.; Beeler, J.; Akib, A.; Muhilal; Audet, S.; Sommer, A. 1995: Reduced seroconversion to measles in infants given vitamin A with measles vaccination Lancet 345(8961): 1330-1332Bridges-Webb, C. 1991: Measles immunisation in Australian children Australian Family Physician 20(6): 709-710
Cullen, R.M.; Walker, W.J. 1996: Measles epidemics 1949-91: the impact of mass immunisation in New Zealand New Zealand Medical Journal 109(1032): 400-402
Cozzi Lepri, A.; Phillips, A.N.; Pezzotti, P.; Mocroft, A.; Sabin, C.A.; Porter, K.; Rezza, G. 1998: Evaluating the effect of year of seroconversion on HIV progression in cohort studies. Italian Seroconversion Study Aids 12(11): 1353-1360
Oruamabo, R.S.; Okoji, G.O. 1987: Immunisation status of children in Port Harcourt before and after commencing the expanded programme on immunisation Public Health 101(6): 447-452
Nuwaha, F.; Kabwongyera, E.; Mulindwa, G.; Barenzi, E. 2000: National immunisation days for polio eradication in Uganda: did immunisation cards increase coverage? East African Medical Journal 77(2): 66-70
Tikhonova, N.T.; Khrometskaia, T.M.; Livanova, L.V.; Poliakova, T.A.; Azarova, S.A. 1978: Several indices of humoral anti-measles immunity in children, previously immunized with live measles vaccine, who have developed measles Voprosy Virusologii 3: 322-327
Banerjee, A.Vinayak.; Duflo, E.; Glennerster, R.; Kothari, D. 2010: Improving immunisation coverage in rural India: clustered randomised controlled evaluation of immunisation campaigns with and without incentives Bmj 340: C2220
Sasaki, S.; Igarashi, K.; Fujino, Y.; Comber, A.J.; Brunsdon, C.; Muleya, C.Mbwili.; Suzuki, H. 2011: The impact of community-based outreach immunisation services on immunisation coverage with GIS network accessibility analysis in peri-urban areas, Zambia Journal of Epidemiology and Community Health 65(12): 1171-1178
Bennett, J.V.; Fernandez de Castro, J.; Valdespino-Gomez, J.Luis.; Garcia-Garcia, M.de.Lourdes.; Islas-Romero, R.; Echaniz-Aviles, G.; Jimenez-Corona, A.; Sepulveda-Amor, J. 2002: Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren Bulletin of the World Health Organization 80(10): 806-812
Martins, C.; Garly, M-Lill.; Bale, C.; Rodrigues, A.; Benn, C.S.; Whittle, H.; Aaby, P. 2013: Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines Vaccine 31(48): 5766-5771
Schluter, P.J.; Ford, R.P. 1998: Immunisation timeliness for a birth cohort in Christchurch. Christchurch Immunisation Coordination Study Group New Zealand Medical Journal 111(1073): 336-340
Bell, D.W.; Ford, R.P.; Slade, B.; McCormack, S.P. 1997: Immunisation coverage in Christchurch in a birth cohort. Christchurch Immunisation Coordination Committee New Zealand Medical Journal 110(1056): 440-442
Kuwajima, S. 1986: Studies on the interaction between cells infected with measles virus and anti-measles antibody. I. Cytotoxic antibody activity of sera obtained from patients with natural measles and subacute sclerosing panencephalitis by use of chronically infected cell lines Hokkaido Journal of Medical Science 61(1): 5-14
Kurien, B.T.; Dorri, Y.; Bachmann, M.; Scofield, R.H. 2012: Induction of anti-Ro60/anti-la by immunisation with spectrin and induction of anti-spectrin by immunisation with Ro60 and 4-hydroxy-2-nonenal-modified Ro60 immunisation Clinical and Experimental Rheumatology 30(6): 886-893
Elliott, A.M.; Mawa, P.A.; Webb, E.L.; Nampijja, M.; Lyadda, N.; Bukusuba, J.; Kizza, M.; Namujju, P.B.; Nabulime, J.; Ndibazza, J.; Muwanga, M.; Whitworth, J.A.G. 2010: Effects of maternal and infant co-infections, and of maternal immunisation, on the infant response to BCG and tetanus immunisation Vaccine 29(2): 247-255
2011: Measles outbreaks and progress toward measles preelimination --- African region, 2009-2010 MMWR. Morbidity and mortality weekly report 60(12): 374-378
Techasena, W.; Sriprasert, P.; Pattamadilok, S.; Wongwacharapipoon, P. 2007: Measles antibody in mothers and infants 0-2 years and response to measles vaccine at the age of 9 and 18 months Journal of the Medical Association of Thailand 90(1): 106-112
Bjerregaard, P.; Pedersen, K.M.; Kamper-Jørgensen, F.; Koch, C.; Pedersen, F.K.; Wagner, A.L.; Zoffmann, H. 1985: Vaccination against measles, mumps and German measles. II. Socio-economic analysis Ugeskrift for Laeger 147(38): 3017-3022
Bjerregaard, P.; Pedersen, K.M.; Kamper-Jørgensen, F.; Koch, C.; Pedersen, F.K.; Wagner, A.L.; Zoffmann, H. 1985: Vaccination against measles, mumps and German measles. I. Medical and epidemiological aspects Ugeskrift for Laeger 147(38): 3013-3017